DOW JONES21,190.55-726.61 -3.32%
S&P 5002,493.12-91.47 -3.54%
NASDAQ7,411.46-288.64 -3.75%

B. Riley FBR Maintains Buy on Novavax, Raises Price Target to $16

B. Riley FBR maintains Novavax (NASDAQ:NVAX) with a Buy and raises the price target from $12 to $16.

Benzinga · 02/28/2020 12:36

B. Riley FBR maintains Novavax (NASDAQ:NVAX) with a Buy and raises the price target from $12 to $16.